Learn More
Medchemexpress LLC Soticlestat | 1429505-03-2 | 99.8% | 373.45 | 100 MG

Supplier: Medchemexpress LLC HY10912310MG
Soticlestat is a first-in-class, potent, selective, and orally active cholesterol 24-hydroxylase (CH24H) inhibitor with potential for epilepsy syndromes research.
- Inhibits the catalytic activity of human cholesterol 24-hydroxylase (CH24H) with an IC50 of 4.5 nM.
- Lowers brain 24S-hydroxycholesterol in a dose-dependent manner.
- Significantly reduces premature deaths in APP/PS1-Tg mice.
- Suppresses potassium-evoked extracellular glutamate elevations in the hippocampus.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.